AACR logo

More articles from Article

Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells
Roberto R. Rosato, Jorge A. Almenara, Sonia C. Maggio, Peter Atadja, Ruth Craig, Julie Vrana, Paul Dent, Steven Grant

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1772-1785; DOI: 10.1158/1535-7163.MCT-05-0157
Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors
Shinji Sakai, Kenji Kawabata, Shinji Tanaka, Norifumi Harimoto, Ichiro Hashimoto, Changjun Mu, Brian Salmons, Hiroyuki Ijima, Koei Kawakami

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1786-1790; DOI: 10.1158/1535-7163.MCT-05-0227
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma
Dimpy Koul, Ruijun Shen, Sherry Bergh, Yiling Lu, John F. de Groot, Ta Jen Liu, Gordon B. Mills, W.K. Alfred Yung

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1681-1688; DOI: 10.1158/1535-7163.MCT-05-0258
The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells
Linda C. Hsi, Xiaopei Xi, Yuanqing Wu, Scott M. Lippman

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1740-1746; DOI: 10.1158/1535-7163.MCT-05-0218
A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells
Kazuki Yamanaka, Palma Rocchi, Hideaki Miyake, Ladan Fazli, Bob Vessella, Uwe Zangemeister-Wittke, Martin E. Gleave

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1689-1698; DOI: 10.1158/1535-7163.MCT-05-0064
Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak
Shivendra V. Singh, Yan Zeng, Dong Xiao, Victor G. Vogel, Joel B. Nelson, Rajiv Dhir, Yamini B. Tripathi

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1747-1754; DOI: 10.1158/1535-7163.MCT-05-0223
Role of O⁶-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine
Kimiko Ishiguro, Krishnamurthy Shyam, Philip G. Penketh, Alan C. Sartorelli

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1755-1763; DOI: 10.1158/1535-7163.MCT-05-0169
Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model
Romyla Ilagan, Liquin Joann Zhang, Jill Pottratz, Kim Le, Sussan Salas, Meera Iyer, Lily Wu, Sanjiv S. Gambhir, Michael Carey

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1662-1669; DOI: 10.1158/1535-7163.MCT-05-0197
Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells
Hiroji Uemura, Hitoshi Ishiguro, Yoji Nagashima, Takeshi Sasaki, Noboru Nakaigawa, Hisashi Hasumi, Shingo Kato, Yoshinobu Kubota

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1699-1709; DOI: 10.1158/1535-7163.MCT-04-0295
Biological and molecular properties of a new α_vβ₃/α_vβ₅ integrin antagonist
Laura Belvisi, Teresa Riccioni, Marcella Marcellini, Loredana Vesci, Ilaria Chiarucci, Daniela Efrati, Donatella Potenza, Carlo Scolastico, Leonardo Manzoni, Katia Lombardo, M. Antonietta Stasi, Augusto Orlandi, Alessandro Ciucci, Beatrice Nico, Domenico Ribatti, Giuseppe Giannini, Marco Presta, Paolo Carminati, Claudio Pisano

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1670-1680; DOI: 10.1158/1535-7163.MCT-05-0120

Main menu

User menu

Search

More articles from Article

Pages

Articles

Info for

About MCT